Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Bupropion Hydrobromide

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 164Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 905818-69-1, Aplenzin, Bupropion hbr, Bupropion hydrobromide [usan], Bupropion (hydrobromide), 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one hydrobromide
    Molecular Formula
    C13H19BrClNO
    Molecular Weight
    320.65  g/mol
    InChI Key
    WSTCENNATOVXKQ-UHFFFAOYSA-N
    FDA UNII
    E70G3G5863
    Bupropion Hydrobromide is the hydrobromide salt of an aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown. This agent does not inhibit monoamine oxidase and, compared to classical tricyclic antidepressants, is a weak blocker of the neuronal uptake of serotonin and norepinephrine. Buproprion also weakly inhibits the neuronal re-uptake of dopamine.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrobromide
    2.1.2 InChI
    InChI=1S/C13H18ClNO.BrH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H
    2.1.3 InChI Key
    WSTCENNATOVXKQ-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Br
    2.2 Other Identifiers
    2.2.1 UNII
    E70G3G5863
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 905818-69-1

    2. Aplenzin

    3. Bupropion Hbr

    4. Bupropion Hydrobromide [usan]

    5. Bupropion (hydrobromide)

    6. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one Hydrobromide

    7. Bvf-033

    8. E70g3g5863

    9. Bupropion Hydrobromide (usan)

    10. Aplenzin Er

    11. Unii-e70g3g5863

    12. Aplenzin (tn)

    13. Schembl636116

    14. Chembl1201735

    15. Dtxsid20920317

    16. Bupropion Hydrobromide [mi]

    17. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,hydrobromide

    18. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrobromide

    19. Bupropion Hydrobromide [vandf]

    20. Akos015917698

    21. Bupropion Hydrobromide [mart.]

    22. Bupropion Hydrobromide [usp-rs]

    23. Bupropion Hydrobromide [who-dd]

    24. Bupropion Hydrobromide [orange Book]

    25. D07938

    26. Q27276951

    27. (2rs)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)propan-1-one Hbr

    28. (2rs)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)propan-1-one Hydrobromide

    29. 1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, Hbr (1:1)

    30. 1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, Hydrobromide (1:1)

    31. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one--hydrogen Bromide (1/1)

    2.4 Create Date
    2007-01-10
    3 Chemical and Physical Properties
    Molecular Weight 320.65 g/mol
    Molecular Formula C13H19BrClNO
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count4
    Exact Mass319.03385 g/mol
    Monoisotopic Mass319.03385 g/mol
    Topological Polar Surface Area29.1 Ų
    Heavy Atom Count17
    Formal Charge0
    Complexity247
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameAplenzin
    Active IngredientBupropion hydrobromide
    Dosage FormTablet, extended release
    RouteOral
    Strength348mg; 522mg; 174mg
    Market StatusPrescription
    CompanyValeant Bermuda

    2 of 4  
    Drug NameBupropion hydrobromide
    PubMed HealthBupropion (By mouth)
    Drug ClassesAntidepressant, Smoking Cessation Agent
    Active IngredientBupropion hydrobromide
    Dosage FormTablet, extended release
    Routeoral
    Strength522mg; 174mg
    Market StatusTentative Approval
    CompanyWatson Labs

    3 of 4  
    Drug NameAplenzin
    Active IngredientBupropion hydrobromide
    Dosage FormTablet, extended release
    RouteOral
    Strength348mg; 522mg; 174mg
    Market StatusPrescription
    CompanyValeant Bermuda

    4 of 4  
    Drug NameBupropion hydrobromide
    PubMed HealthBupropion (By mouth)
    Drug ClassesAntidepressant, Smoking Cessation Agent
    Active IngredientBupropion hydrobromide
    Dosage FormTablet, extended release
    Routeoral
    Strength522mg; 174mg
    Market StatusTentative Approval
    CompanyWatson Labs

    5 Pharmacology and Biochemistry
    5.1 FDA Pharmacological Classification
    5.1.1 Pharmacological Classes
    Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]; Aminoketone [EPC]